Wanbury Limited (WANBURY) — Corporate Action | 11 August 2026

11 August 2026 · NSE 🔴 High Importance Neutral

By StockFin Research Team•AI-Assisted Analysis•Source: BSE/NSE Filings

📢 Key Event

Board approves ESOP share allotment and director re-appointment

🔮 What's Next

Re-appointment of Mr. Mohan Kumar Rayana as whole-time director for five years, effective August 21, 2026, pending shareholder approval

💡 Investor Takeaway

The share allotment dilutes existing shareholders' stakes while the director re-appointment signals continuity in leadership.

Wanbury Limited announced the allotment of 27,530 equity shares to eligible employees who exercised vested options under its ESOP 2016, increasing the paid-up share capital from [amount not verified] to [amount not verified]. The Board also approved the re-appointment of Mr. Mohan Kumar Rayana as a whole-time director for five years, effective August 21, 2026, subject to shareholder approval. The unaudited Q1 results showed diluted EPS of ₹0.92 and total comprehensive income of [amount not verified].

📄 View Original Announcement (PDF)

📊 Stock Analysis — WANBURY ✨ Ask AI About This

About Wanbury Limited (WANBURY)

Healthcare · Pharmaceuticals · Listed on NSE

Market Cap: ₹758.71 CrP/E: 16.6ROE: 80.7%ROCE: 34.9%

View full WANBURY stock details →

📡 Get AI alerts when WANBURY files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track WANBURY — Free

💡 Ask AI about this filing

"How will the new share issuance affect EPS and share price?""What is the current market price of WANBURY shares?""When will shareholder approval for the director re-appointment be sought?"

Ask AI Free →

📊 More WANBURY filings

Announcement — 29 September 2026Wanbury Ltd announced the closure of its insider trading window effective October 1, 2026, covering ...
🟡 Board Meeting — 24 September 2026Wanbury Limited announced at its 38th Annual General Meeting on September 24, 2026, the appointment ...
🟡 Board Meeting — 24 September 2026Wanbury Ltd held its 38th AGM on September 24, 2026, approving audited FY2026 financials, reappointi...
🟡 Board Meeting — 31 August 2026Wanbury Ltd announced that its 38th Annual General Meeting will be held on 24 September 2026 via vid...
🔴 Annual Report — 31 August 2026Wanbury Ltd's 2025-26 Annual Report shows revenue of ₹65,120.54 lakhs and net profit of ₹6,613.47 la...

See all WANBURY filings →

🔥 Also filed on 11 August 2026

ULTRACEMCOUltraTech Cement LimitedAnnouncement SUDEEPPHRMSudeep Pharma LimitedFinancial Results SUTLEJTEXSutlej Textiles and Industries LimitedFinancial Results RBZJEWELRBZ Jewellers LimitedFinancial Results TATVATatva Chintan Pharma Chem LimitedCorporate Action AETHERAether Industries LimitedCorporate Action

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when WANBURY files new disclosures

Track WANBURY filings, board meetings, and corporate actions. Free email alerts at 5 PM.